Literature DB >> 22580137

Synthesis, spectroscopic and biological activities studies of acyclic and macrocyclic mono and binuclear metal complexes containing a hard-soft Schiff base.

Azza A A Abou-Hussein1, Wolfgang Linert.   

Abstract

Mono- and bi-nuclear acyclic and macrocyclic complexes with hard-soft Schiff base, H(2)L, ligand derived from the reaction of 4,6-diacetylresorcinol and thiocabohydrazide, in the molar ratio 1:2 have been prepared. The H(2)L ligand reacts with Co(II), Ni(II), Cu(II), Zn(II), Mn(II) and UO(2)(VI) nitrates, VO(IV) sulfate and Ru(III) chloride to get acyclic binuclear complexes except for VO(IV) and Ru(III) which gave acyclic mono-nuclear complexes. Reaction of the acyclic mono-nuclear VO(IV) and Ru(III) complexes with 4,6-diacetylresorcinol afforded the corresponding macrocyclic mono-nuclear VO(IV) and Ru(IIII) complexes. Template reactions of the 4,6-diacetylresorcinol and thiocarbohydrazide with either VO(IV) or Ru(III) salts afforded the macrocyclic binuclear VO(IV) and Ru(III) complexes. The Schiff base, H(2)L, ligand acts as dibasic with two NSO-tridentate sites and can coordinate with two metal ions to form binuclear complexes after the deprotonation of the hydrogen atoms of the phenolic groups in all the complexes, except in the case of the acyclic mononuclear Ru(III) and VO(IV) complexes, where the Schiff base behaves as neutral tetradentate chelate with N(2)S(2) donor atoms. The ligands and the metal complexes were characterized by elemental analysis, IR, UV-vis (1)H-NMR, thermal gravimetric analysis (TGA) and ESR, as well as the measurements of conductivity and magnetic moments at room temperature. Electronic spectra and magnetic moments of the complexes indicate the geometries of the metal centers are either tetrahedral, square planar or octahedral. Kinetic and thermodynamic parameters were calculated using Coats-Redfern equation, for the different thermal decomposition steps of the complexes. The ligands and the metal complexes were screened for their antimicrobial activity against Staphylococcus aureus as Gram-positive bacteria, and Pseudomonas fluorescens as Gram-negative bacteria in addition to Fusarium oxysporum fungus. Most of the complexes exhibit mild antibacterial and antifungal activities against these organisms.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22580137     DOI: 10.1016/j.saa.2012.04.057

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  5 in total

1.  A New Photoactivatable Ruthenium(II) Complex with an Asymmetric Bis-Thiocarbohydrazone: Chemical and Biological Investigations.

Authors:  Marianna Pioli; Nicolò Orsoni; Mirco Scaccaglia; Rossella Alinovi; Silvana Pinelli; Giorgio Pelosi; Franco Bisceglie
Journal:  Molecules       Date:  2021-02-10       Impact factor: 4.411

2.  Synthesis, spectroscopic, coordination and biological activities of some organometallic complexes derived from thio-Schiff base ligands.

Authors:  Azza A Abou-Hussein; Wolfgang Linert
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2013-07-01       Impact factor: 4.098

3.  Syntheses, characterization, and biological activity of novel mono- and binuclear transition metal complexes with a hydrazone Schiff base derived from a coumarin derivative and oxalyldihydrazine.

Authors:  Esther Theresa Knittl; Azza A Abou-Hussein; Wolfgang Linert
Journal:  Monatsh Chem       Date:  2017-11-27       Impact factor: 1.451

4.  Co(ii), Ni(ii), Cu(ii) and Cd(ii)-thiocarbonohydrazone complexes: spectroscopic, DFT, thermal, and electrical conductivity studies.

Authors:  R Fouad; Ibrahim A Shaaban; Tarik E Ali; Mohammed A Assiri; S S Shenouda
Journal:  RSC Adv       Date:  2021-11-23       Impact factor: 4.036

Review 5.  Biological Applications of Thiocarbohydrazones and Their Metal Complexes: A Perspective Review.

Authors:  Carmela Bonaccorso; Tiziano Marzo; Diego La Mendola
Journal:  Pharmaceuticals (Basel)       Date:  2019-12-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.